Company profile for BigHat Biosciences

NEW Drugs in Dev.: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BigHat Biosciences’ mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. BigHat integrates a wet lab for high-speed characterization with machine learning technologies to guide the search for better antibodies. ‍We are applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s m...
BigHat Biosciences’ mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. BigHat integrates a wet lab for high-speed characterization with machine learning technologies to guide the search for better antibodies. ‍We are applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
733 Industrial Road San Carlos, CA 94070
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250417061472/en/BigHat-Biosciences-and-Lilly-Collaborate-to-Advance-AI-Driven-Antibody-Therapeutics

BUSINESSWIRE
17 Apr 2025

https://www.indianpharmapost.com/news/lonzas-synaffix-collaborates-with-bighat-biosciences-for-ml-designed-adc-16386

INDPHARMAPOST
05 Nov 2024

https://www.theguardian.com/global-development/2024/apr/25/cost-of-developing-new-drugs-may-be-far-lower-than-industry-claims-trial-reveals

THEGAURDIAN
25 Apr 2024

https://www.businesswire.com/news/home/20240424268055/en

BUSINESSWIRE
24 Apr 2024

https://news.abbvie.com/2023-12-05-AbbVie-and-BigHat-Biosciences-Announce-Research-Collaboration-to-Leverage-Artificial-Intelligence-and-Machine-Learning-to-Discover-Next-Generation-Therapeutic-Antibodies

PRESS RELEASE
05 Dec 2023
BigHat keeps dry amid stormy market, signs deal with Merck & Co.
BigHat keeps dry amid stormy market, signs deal with Merck & Co.

29 Nov 2022

// Gabrielle Masson FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/exclusive-bighat-cherry-picking-opportunities-amid-stormy-market-pens-pact-big-pharma-merck

Gabrielle Masson FIERCEBIOTECH
29 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty